Process of manufacture of annexin v
US-2024116982-A1 · Apr 11, 2024 · US
US11535646B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11535646-B2 |
| Application number | US-201816758653-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2018 |
| Priority date | Oct 27, 2017 |
| Publication date | Dec 27, 2022 |
| Grant date | Dec 27, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to an improved method of purifying an immunoglobulin, and more particularly to a method of purifying an immunoglobulin which is capable of sufficiently removing impurities from an immunoglobulin-containing plasma protein sample through a simple process, comprising a single anion-exchange chromatography and a single cation-exchange chromatography.
Opening claim text (preview).
The invention claimed is: 1. A method of purifying an immunoglobulin, the method comprising: (a) subjecting an immunoglobulin-containing plasma sample to anion-exchange chromatography to obtain a fraction that is not attached to an anion-exchange chromatography column; and (b) subjecting the obtained fraction to cation-exchange chromatography, wherein the cation-exchange chromatography of process (b) above comprises eluting the immunoglobulin at a salt concentration of 200 mM to 300 mM, and wherein, after process (b) above, additional ion-exchange chromatography is not performed. 2. The method according to claim 1 , wherein the immunoglobulin-containing plasma sample is obtained using a method comprising: (i) dissolving immunoglobulin-containing plasma protein fraction I+II+III or fraction II+III, and then performing a precipitation reaction by adding a precipitant; and (ii) removing the precipitate and obtaining an immunoglobulin-containing supernatant. 3. The method according to claim 2 , wherein the precipitant of process (i) above is caprylic acid. 4. The method according to claim 1 , wherein the anion-exchange chromatography of process (a) above is performed at a pH ranging from 5.8 to 6.2. 5. The method according to claim 1 , wherein the cation-exchange chromatography of process (b) above comprises eluting the immunoglobulin using a sodium chloride-containing buffer. 6. The method according to claim 1 , further comprising, between processes (a) and (b) above, inactivating virus by adding a surfactant. 7. The method according to claim 1 , wherein an immunoglobulin having a purity of 96% or more is obtained by the method. 8. The method according to claim 1 , wherein the method does not further comprise, after process (b) above, a pH adjustment process, a precipitation process, or a solvent or detergent treatment process.
Ion-exchange chromatography · CPC title
by a combination of two or more processes of different types · CPC title
by precipitation · CPC title
by filtration, ultrafiltration or reverse osmosis · CPC title
Purification · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.